CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Open-market buy Chief Financial Officer bought 9,490 shares at $7.90 ($74,971)
- 4 Shares withheld for taxes Chief Financial Officer gave up 285 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Business Officer bought 14,705 shares at $6.80 ($99,959)
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $7.32 ($43,895)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Pres and CEO gave up 4,437 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,407 shares (to pay taxes)
- 4 Option exercise Director acquired 16,500 shares (option exercise)
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $10.28 ($61,663)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 249 shares (option exercise)
- 8-K Event Executive or director change
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 4 Option exercise Director acquired 4,507 shares (option exercise)
- 4 Option exercise Director acquired 4,507 shares (option exercise)
Page 12 of 44 · 872 filings